Antibacterial activities of cefpodoxime, cefixime, and ceftriaxone.
about
Pharmacokinetics of ceftriaxone in plasma and bone of patients undergoing hip or knee surgery.Penetration of cefpodoxime into uterine and vaginal secretions from postpartum women after a single oral dose of cefpodoxime proxetil.Antimicrobial activity of DU-6681a, a parent compound of novel oral carbapenem DZ-2640In vitro activities and targets of three cephem antibiotics against Haemophilus influenzaeComparative in vitro activity of cefixime against Haemophilus influenzae isolates, including ampicillin-resistant, non-beta-lactamase-producing isolates, from pediatric patients.Shedding of Clostridium difficile, fecal beta-lactamase activity, and gastrointestinal symptoms in 51 volunteers treated with oral cefixime.Presence of Clostridium difficile and antibiotic and beta-lactamase activities in feces of volunteers treated with oral cefixime, oral cefpodoxime proxetil, or placebo.Ceftriaxone prophylaxis in abdominal, cardiovascular, thoracic, orthopaedic, neurosurgical and general surgery: a review of practice 1996 - 2003.Susceptibility of Neisseria gonorrhoeae to cefpodoxime: determination of MICs and disk diffusion zone diametersPenetration of cefpodoxime proxetil in lung parenchyma and epithelial lining fluid of noninfected patientsPharmacokinetics and tissue penetration of a single dose of ceftriaxone (1,000 milligrams intravenously) for antibiotic prophylaxis in thoracic surgery.Penetration of ceftriaxone (1 or 2 grams intravenously) into mediastinal and cardiac tissues in humans.Concentrations of ceftriaxone (1,000 milligrams intravenously) in abdominal tissues during open prostatectomy.Pharmacokinetics and inflammatory fluid penetration of cefpodoxime proxetil in volunteers.Comparative in vitro activity and beta-lactamase stability of FK482, a new oral cephalosporin.Pharmacokinetics of cefpodoxime proxetil and interactions with an antacid and an H2 receptor antagonist.Orally administered cefpodoxime proxetil for treatment of uncomplicated gonococcal urethritis in males: a dose-response study.Spectrofluorimetric determination of cefixime using terbium-danofloxacin probe.Comparison of cefprozil, cefpodoxime proxetil, loracarbef, cefixime, and ceftibuten.Ceftriaxone (1 g intravenously) penetration into abdominal tissues when administered as antibiotic prophylaxis during nephrectomy.In vitro activity of cefpodoxime against bacterial isolates obtained from patients with cancer.Chitosan-based electrospun nanofibrous mats, hydrogels and cast films: novel anti-bacterial wound dressing matrices.In vitro susceptibility of Helicobacter pylori to the new oral cephalosporins cefpodoxime, ceftibuten and cefixime.
P2860
Q30317265-ADE8C0DF-425B-4B8C-8F1E-AF8BF15D1C48Q35126031-9A968BC6-34B6-4997-88F5-25D59806735CQ35136539-284B0C9C-E160-418C-A621-C91CB27FB4D3Q35358847-FA687969-EAA4-4B3C-8E3A-7F788A92F63CQ35565470-EC1B7B16-AF99-4F4F-8441-BD2BFC8AC4E3Q35816798-EB0C063A-A184-4DCC-9612-563DE7893DB3Q35900521-43880C66-A124-4AFC-B05E-21D36B7F3D81Q36325993-61933003-CB5E-4451-8C8D-AA8B0188437CQ36753094-E1EAAC6B-D38C-4FD9-B0AC-28372AA32CBBQ36757699-CC3A3EEB-9A90-4C4C-A369-10E85FC3D21FQ36758389-1831AE8A-80B9-4A68-B464-3570838C0ACAQ39781743-615D4FC5-8478-403A-85F1-4BB709C07066Q39782167-F49F2436-C8A9-48AF-80A4-9F6B317527E9Q39815334-E1CE5FD3-7752-4F67-AE10-13A856F9EA2BQ39820140-B4F36AE2-8D31-4D28-98A3-FB2E18FE7029Q39871651-2DDB72CE-414A-4694-A5C6-79B7197FD5EAQ39881220-8C68C1F5-1A1C-4D6C-85EF-16A191D3D9A9Q40333700-81BCFAA3-F5ED-4726-B349-4D957E4999D1Q41132894-86BA8EFA-7DB4-47CF-9734-EDEE86CFB1C4Q44313958-CEE48523-CAD1-4C3D-9278-342E08959765Q44432954-0A1A8795-9695-4848-9835-21089A6FCCC6Q50451110-9EBC7233-9E3E-4071-984B-97DBF772C930Q54316634-A00CFBD7-DC8E-430D-9E68-35CBBB006553
P2860
Antibacterial activities of cefpodoxime, cefixime, and ceftriaxone.
description
1988 nî lūn-bûn
@nan
1988年の論文
@ja
1988年論文
@yue
1988年論文
@zh-hant
1988年論文
@zh-hk
1988年論文
@zh-mo
1988年論文
@zh-tw
1988年论文
@wuu
1988年论文
@zh
1988年论文
@zh-cn
name
Antibacterial activities of cefpodoxime, cefixime, and ceftriaxone.
@ast
Antibacterial activities of cefpodoxime, cefixime, and ceftriaxone.
@en
type
label
Antibacterial activities of cefpodoxime, cefixime, and ceftriaxone.
@ast
Antibacterial activities of cefpodoxime, cefixime, and ceftriaxone.
@en
prefLabel
Antibacterial activities of cefpodoxime, cefixime, and ceftriaxone.
@ast
Antibacterial activities of cefpodoxime, cefixime, and ceftriaxone.
@en
P2093
P2860
P356
P1476
Antibacterial activities of cefpodoxime, cefixime, and ceftriaxone.
@en
P2093
Sierra-Madero J
Washington JA
P2860
P304
P356
10.1128/AAC.32.12.1896
P407
P577
1988-12-01T00:00:00Z